Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia

被引：8

作者：

Anoop, Parameswaran ^{[1
]}

Wotherspoon, Andy ^{[2
]}

Matutes, Estella ^{[1
]}

机构：

[1] Royal Marsden NHS Fdn Trust, Inst Canc Res, Dept Haematol, London, England

[2] Royal Marsden NHS Fdn Trust, Inst Canc Res, Dept Histopathol, London, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 148卷 / 03期

关键词：

chronic lymphocytic leukaemia; hepatitis; infection; B-CELL LYMPHOMA; CHEMOTHERAPY; RITUXIMAB; CANCER;

D O I：

10.1111/j.1365-2141.2009.07972.x

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：484 / 486

页数：3

共 10 条

[1]

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs [J].

Besson, C ;

Canioni, D ;

Lepage, E ;

Pol, S ;

Morel, P ;

Lederlin, P ;

Van Hoof, A ;

Tilly, H ;

Gaulard, P ;

Coiffier, B ;

Gisselbrecht, C ;

Brousse, N ;

Reyes, F ;

Hermine, O .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :953-960

[2]

Does rituximab really induce hepatitis C virus reactivation? [J].

Ennishi, Daisuke ;

Yokoyama, Masahiro ;

Terui, Yasuhito ;

Takeuchi, Kengo ;

Ikeda, Kazuma ;

Tanimoto, Mitsune ;

Hatake, Kiyohiko .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) :4695-4696

[3]

Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy [J].

Ennishi, Daisuke ;

Terui, Yasuhito ;

Yokoyama, Masahiro ;

Mishima, Yuko ;

Takahashi, Shunji ;

Takeuchi, Kengo ;

Okamoto, Hiroaki ;

Tanimoto, Mitsune ;

Hatake, Kiyohiko .

AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (01) :59-62

[4]

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines [J].

Hallek, Michael ;

Cheson, Bruce D. ;

Catovsky, Daniel ;

Caligaris-Cappio, Federico ;

Dighiero, Guillaume ;

Doehner, Hartmut ;

Hillmen, Peter ;

Keating, Michael J. ;

Montserrat, Emili ;

Rai, Kanti R. ;

Kipps, Thomas J. .

BLOOD, 2008, 111 (12) :5446-5456

[5]

Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma [J].

Hsieh, Ching-Yun ;

Huang, Hsin-Hui ;

Lin, Chen-Yuan ;

Chung, Lo Woei ;

Liao, Yu-Mine ;

Bai, Li-Yuan ;

Chiu, Chang-Fang .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2584-2586

[6]

Reactivation of hepatitis C virus after chemotherapy for colon cancer [J].

Melisko, ME ;

Fox, R ;

Venook, A .

CLINICAL ONCOLOGY, 2004, 16 (03) :204-205

[7]

Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses [J].

Milligan, DW ;

Fernandes, S ;

Dasgupta, R ;

Davies, FE ;

Matutes, E ;

Fegan, CD ;

McConkey, C ;

Child, JA ;

Cunningham, D ;

Morgan, GJ ;

Catovsky, D .

BLOOD, 2005, 105 (01) :397-404

[8]

Reactivation of chronic hepatitis C virus infection by immunoadsorption in factor VIII inhibitor haemophilia [J].

Rommel, F ;

Toepfer, M ;

Eberle, J ;

Schiffl, H ;

Spannagl, M ;

Schramm, W .

THROMBOSIS AND HAEMOSTASIS, 2000, 84 (04) :733-734

[9]

Zuckerman E, 1998, CANCER-AM CANCER SOC, V83, P1224, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1224::AID-CNCR23>3.3.CO

[10]

2-#

← 1 →